Biochemistry, Genetics and Molecular Biology
Cancer Cell
80%
BRCA1
45%
N-Myc
32%
DNA Repair
29%
P53
29%
Gene Expression
28%
Histone Deacetylase
28%
Downregulation
24%
Homologous Recombination
22%
Androgen Receptor
21%
Mitochondrion
21%
Linoleic Acid
21%
Enzalutamide
16%
Microarrays
14%
Cell Cycle Arrest
13%
Polyunsaturated Fatty Acid
12%
Homeostasis
12%
Messenger RNA
12%
Metastasis Suppressor
11%
Cell Growth
10%
Nuclear Export
10%
Cell Motility
10%
Hypoxia Inducible Factor 1
10%
Chromosome Instability
10%
Nuclear Gene
10%
Heat Shock Protein
10%
Cadherin
10%
Cell Invasion
10%
Autophagosome
10%
LNCaP
10%
Transcription Factor E2F1
10%
Centrosome
10%
Immune Checkpoints
10%
Suppressor Gene
10%
Uracil-DNA Glycosylase
10%
ID1
10%
Autophagy
10%
Lysosome
10%
Genome Instability
10%
Estradiol
9%
Cell Cycle Regulation
9%
Uracil
9%
Mitochondrial DNA
8%
Glycosylase
7%
Tumor Suppressor Gene
6%
Signal Transduction
6%
Tumor Progression
6%
Wild Type
5%
Upregulation
5%
Protein Expression
5%
Keyphrases
Bipolar Androgen Therapy
43%
Histone Deacetylase Inhibitor (HDACi)
32%
BRCA1 Gene
32%
Prostate Cancer Cells
29%
Metastatic Castration-resistant Prostate Cancer (mCRPC)
21%
N-Myc
21%
MCF-7 Cells
21%
Downregulated Genes
21%
Androgens
20%
Breast Cancer Susceptibility Gene 1 (BRCA1)
18%
Enzalutamide
17%
Prostate Cancer
17%
Supraphysiological
16%
Androgen Receptor
15%
Gene Expression
15%
Hypoxia
15%
Hypoxia-inducible factor-1α (HIF-1α)
15%
Breast Cancer
14%
PC-3 Cells
14%
Androgen Signaling
13%
Advanced Prostate Cancer
12%
Testosterone
12%
Human Prostate Cancer Cells
11%
Prostate Cancer Cell Lines
11%
Tumor Protein p53 (TP53)
11%
Clinical Characterization
10%
Cell Motility
10%
Antitumor Effect
10%
Tasquinimod
10%
Variable Sensitivity
10%
Allosteric Modulator
10%
Angiogenesis
10%
Linoleic Acid
10%
PTK787
10%
Metastasis Suppressor
10%
Vascular Endothelial Growth Factor Receptor Inhibitor
10%
Microarray Experiment
10%
Prostate Metastasis
10%
Bortezomib
10%
Homeostasis
10%
AMG 900
10%
Multiple Loops
10%
Polo-like Kinase Inhibitor
10%
Small Molecule Screening
10%
Rab4A
10%
Chromosomal Instability
10%
COX-II
10%
Cell Invasion
10%
Genomic Response
10%
Genome Stability
10%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Histone Deacetylase Inhibitor
47%
Androgen
44%
Castration Resistant Prostate Cancer
25%
Androgen Receptor
23%
Histone Deacetylase
17%
Sodium Valproate
15%
Neoplasm
12%
Hypoxia Inducible Factor 1
12%
Antitumor Activity
12%
Cancer Growth
12%
Dacinostat
12%
Tumor Growth
11%
Vasculotropin Receptor
10%
Disulfiram
10%
Fatty Acid
10%
Itraconazole
10%
Protein Tyrosine Kinase
10%
Linoleic Acid
10%
Tilorone
10%
Cyclin Dependent Kinase 5
10%
Repurposing
10%
Heat Shock Protein 40
10%
Aurora Kinase Inhibitor
10%
Vatalanib
10%
Irinotecan
10%
Cetrimonium Bromide
10%
Polo Like Kinase 1
10%
Fenugreek
10%
Protein Tyrosine Kinase Inhibitor
10%
Lethality
10%
Hypoxia
10%
Progression Free Survival
8%
Vorinostat
7%
Prostate Specific Antigen
5%
Vasculotropin
5%
Enzalutamide
5%
Combination Therapy
5%
